Trial in Progress: A Phase 1 Study of Revumenib + Intensive Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia Harboring Genetic Alterations in KMT2A, NPM1, or NUP98 (SNDX-5613-0708)

Abstract | Jun 12, 2025

Author

Aldoss I, et al.

Congress

European Hematology Association Annual Congress 2025

Milan, Italy | June 12 – 15, 2025